Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIG1 hypoxia inducible domain family member 1A pseudogene 3 (HIGD1AP3) is a human pseudogene related in sequence to the protein-coding gene HIGD1A, which encodes a mitochondrial protein involved in hypoxic response, apoptosis regulation, and possible disease processes such as ischemic heart disease and neurodegeneration. However, HIGD1APAP3 itself appears to be a non-coding sequence and does not produce a functional protein product. As such, it does not serve as a therapeutic target, biomarker, or entity of direct biological or clinical significance. Its related protein-coding gene, HIGD1A, is sometimes studied in the context of mitochondrial function and disease, but HIGD1AP3, specifically, is not considered a receptor, enzyme, or drug target. If you are seeking information on the functional mitochondrial protein involved in hypoxia response, the correct target would be HIG1 domain family member 1A (HIGD1A) rather than this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIG1 hypoxia inducible domain family member 1A pseudogene 3 (HIGD1AP3).